Alicyclic imidazoles as H3 agents
US6794405B2 · kind B2 · utility
1Cited by
9References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2003 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Aug 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine H3 receptors are involved, such as allergy, inflammation, hypotension, glaucoma, sleeping disorders, states of hyper- and hypo-motility of the gastro-intestinal tract, cardiovascular disease, hypo- and hyper-activity of the central nervous system, Alzheimer's, schizophrenia, obesity and migraines are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.